98%
921
2 minutes
20
Proton exchange membrane (PEM) water electrolysis offers an efficient route to large-scale green hydrogen production, in which the RuO catalyst exhibits superior activity but limited stability. Unveiling the atomic-scale structural evolution during operando reaction conditions is critical but remains a grand challenge for enhancing the durability of the RuO catalyst in the acidic oxygen evolution reaction (a-OER). This study proposes an adaptive machine learning workflow to elucidate the potential-dependent state-to-state global evolution of the RuO(110) surface within a complex composition and configuration space, revealing the correlation between structural patterns and stability. We identify the active state with distorted RuO units that self-evolve at low potential, which exhibits minor Ru dissolution and an activity self-promotion phenomenon. However, this state exhibits a low potential resistance capacity (PRC) and evolves into inert RuO units at elevated potential. To enhance PRC and mitigate the overevolution of the active state, we explore the metal doping engineering and uncover an inverse volcano-type doping rule: the doped metal-oxygen bond strength should significantly differ from the Ru-O bond. This rule provides a theoretical framework for designing stable RuO-based catalysts and clarifies current discrepancies regarding the roles of different metals in stabilizing RuO. Applying this rule, we predict and confirm experimentally that Na can effectively stabilize RuO in its active state. The synthesized Na-RuO operates in a-OER for over 1800 h without any degradation and enables long-term durability in PEM electrolysis. This work enhances our understanding of the operando structural evolution of RuO and aids in designing durable catalysts for a-OER.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/jacs.4c18300 | DOI Listing |
Sud Med Ekspert
January 2025
Ural State Medical University, Ekaterinburg, Russia.
The article presents the study results of publications on the history of forensic medicine in the Forensic Medical Expertise journal for the 1958-2023. The data on the number of publications for the entire specified period are presented, the author's composition and their publication activities have been analyzed. The analysis of publications with classification by the same type of directionality was carried out, the most common thematic units are highlighted.
View Article and Find Full Text PDFJ Agric Food Chem
September 2025
The State Key Laboratory of Food Science and Resources, Jiangnan University, 1800 Lihu Road, Wuxi 214122, China.
This study develops a multienzyme coimmobilization strategy on NTA-functionalized ZIF-8-coated magnetic nanoparticles (NZMNPs) for efficient d-allulose synthesis. Under optimized immobilization conditions (enzyme-to-carrier ratio: 1:50 w/w, 30 min immobilization), the system achieved an immobilization efficiency of 93.7% along with 107.
View Article and Find Full Text PDFNano Lett
September 2025
Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, College of Biology, Aptamer Engineering Center of Hunan Province, Hunan University, Changsha 410082, China.
Interleukin-12 (IL-12) is a robust proinflammatory cytokine that activates immune cells, such as T cells and natural killer cells, to induce antitumor immunity. However, the clinical application of recombinant IL-12 has been limited by systemic immune-related adverse events (irAEs) and rapid degradation. To address these challenges, we employed mRNA technology to encode a tumor-activated IL-12 "lock" fusion protein that offers both therapeutic efficacy and systemic safety.
View Article and Find Full Text PDFJ Oncol Pharm Pract
September 2025
Hematology/Oncology, Scripps Clinic, La Jolla, USA.
IntroductionDaratumumab is a therapeutic cornerstone of the management of multiple myeloma, exerting its anti-myeloma activity through targeting of the cell surface glycoprotein CD38 on plasma cells. While originally given intravenously, the subcutaneous formulation, daratumumab hyaluronidase injection (Dara SC), has been associated with non-inferior efficacy and lower infusion-related reaction rates (IRRs) in the treatment of multiple myeloma and light chain amyloidosis. A noted benefit of Dara SC is a short administration time; however, the optimal observation time post injection to ensure patient safety is unclear from the drug labeling.
View Article and Find Full Text PDFCereb Cortex
August 2025
Department of Psychology, University of Lübeck, Ratzeburger Allee 160, Lübeck 23562, Germany.
The human auditory system must distinguish relevant sounds from noise. Severe hearing loss can be treated with cochlear implants (CIs), but how the brain adapts to electrical hearing remains unclear. This study examined adaptation to unilateral CI use in the first and seventh months after CI activation using speech comprehension measures and electroencephalography recordings, both during passive listening and an active spatial listening task.
View Article and Find Full Text PDF